May 18, 2013 7:34 AM ET

Biotechnology

Company Overview of Ardea Biosciences, Inc.

Company Overview

Ardea Biosciences, Inc., a biotechnology company, focuses on the discovery and development of small-molecule therapeutics for the treatment of gout and cancer in the United States. Its product candidates include Lesinurad (RDEA594), an inhibitor of the URAT1 kidney transporter, which is in Phase III clinical trials for the treatment of gout; BAY 86-9766 (RDEA119), a mitogen-activated ERK kinase (MEK) inhibitor that is in Phase II clinical trials for the treatment of cancer; and RDEA3170, an URAT1 kidney transporter inhibitor, which is in Phase I clinical trials for the treatment of gout. The company has a development and commercialization license agreement with Bayer Healthcare AG to develop...

Detailed Description

4939 Directors Place

San Diego, CA 92121

United States

107 Employees

Phone:

858-652-6500

Fax:

858-625-0760

www.ardeabio.com

Key Executives for Ardea Biosciences, Inc.

Chief Executive Officer
Age: 55
Chief Financial Officer
Age: 52
Chief Operating Officer and Executive Vice President
Age: 51
Senior Vice President of Regulatory Affairs & Development Operations
Age: 52
Chief Medical Officer and Senior Vice President
Age: 57
Compensation as of Fiscal Year 2012.

Ardea Biosciences, Inc. Key Developments

Ardea Biosciences, Inc.(NasdaqGM:RDEA) dropped from Russell 2000 Index

Ardea Biosciences, Inc. will be removed from Russell 2000 Index.

Ardea Biosciences, Inc.(NasdaqGM:RDEA) dropped from Russell 3000 Index

Ardea Biosciences, Inc.will be removed from Russell 3000 Index.

Ardea Biosciences, Inc.(NasdaqGS:RDEA) dropped from NASDAQ Biotechnology Index

Ardea Biosciences, Inc. will be removed from NASDAQ Biotechnology Index

Similar Private Companies By Industry

Company Name Region
Vetritionals, Inc. United States
Chakshu Research, Inc. United States
Quorum Review, Inc. United States
New Chapter, Inc. United States
Cytometix, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
Rush University United States
Greater Houston Partnership United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Ardea Biosciences, Inc., please visit www.ardeabio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.